These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 160740)

  • 21. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.
    Rothwell PM; Charlton D
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):730-5. PubMed ID: 9647300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.
    Kearns PKA; Paton M; O'Neill M; Waters C; Colville S; McDonald J; Young IJB; Pugh D; O'Riordan J; Weller B; MacDougall N; Clemens T; Dibben C; Wilson JF; Castro MC; Ascherio A; Chandran S; Connick P
    J Neurol; 2019 Oct; 266(10):2376-2386. PubMed ID: 31187189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates.
    Schiess N; Huether K; Fatafta T; Fitzgerald KC; Calabresi PA; Blair I; Alsaadi T; Szolics M
    Mult Scler Relat Disord; 2016 Sep; 9():73-9. PubMed ID: 27645349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
    Al-Araji A; Mohammed AI
    J Neurol Sci; 2005 Jul; 234(1-2):67-71. PubMed ID: 15946690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily.
    Nicoletti A; Lo Fermo S; Reggio E; Tarantello R; Liberto A; Le Pira F; Patti F; Reggio A
    J Neurol; 2005 Aug; 252(8):921-5. PubMed ID: 15789132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disability profile of multiple sclerosis in New Zealand.
    Alla S; Pearson JF; Taylor BV; Miller DH; Clarke G; Richardson A; Willoughby E; Abernethy DA; Sabel CE; Mason DF
    J Clin Neurosci; 2016 Jun; 28():97-101. PubMed ID: 26765754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan.
    Itoh T; Aizawa H; Hashimoto K; Yoshida K; Kimura T; Katayama T; Koyama S; Yahara O; Kikuchi K
    J Neurol Sci; 2003 Oct; 214(1-2):7-9. PubMed ID: 12972381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of multiple sclerosis in the Serbian district Sumadija.
    Toncev G; Miletic Drakulic S; Knezevic Z; Boskovic Matic T; Gavrilovic A; Toncev S; Drulovic J; Pekmezovic T
    Neuroepidemiology; 2011; 37(2):102-6. PubMed ID: 21921643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
    Deryck O; Ketelaer P; Dubois B
    J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
    Krause I; Kern S; Horntrich A; Ziemssen T
    Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis in the Shetland Islands: an update.
    Cook SD; MacDonald J; Tapp W; Poskanzer D; Dowling PC
    Acta Neurol Scand; 1988 Feb; 77(2):148-51. PubMed ID: 3259061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and incidence of multiple sclerosis in Panama (2000-2005).
    Gracia F; Castillo LC; Benzadón A; Larreategui M; Villareal F; Triana E; Arango AC; Lee D; Pascale JM; Gomez E; Armien B
    Neuroepidemiology; 2009; 32(4):287-93. PubMed ID: 19246933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
    Tedeholm H; Skoog B; Lisovskaja V; Runmarker B; Nerman O; Andersen O
    J Neurol; 2015 May; 262(5):1148-63. PubMed ID: 25712541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of multiple sclerosis in Lebanon.
    Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
    J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing prevalence and incidence of multiple sclerosis in South East Wales.
    Hirst C; Ingram G; Pickersgill T; Swingler R; Compston DA; Robertson NP
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):386-91. PubMed ID: 18931003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The organisation of health care and epidemiology of multiple sclerosis in France].
    Debouverie M; Rumbach L; Clavelou P
    Rev Neurol (Paris); 2007 Jun; 163(6-7):637-45. PubMed ID: 17607182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.